Have a personal or library account? Click to login
Associations of levels of high-molecular-weight adiponectin, secreted frizzled-related protein 5 and vascular endothelial growth factor-165 with diabetic retinopathy Cover

Associations of levels of high-molecular-weight adiponectin, secreted frizzled-related protein 5 and vascular endothelial growth factor-165 with diabetic retinopathy

By: Yanfang Fu,  Shizhen Ye and  Jianjun Peng  
Open Access
|Oct 2023

References

  1. Bene BA, O’Connor S, Mastellos N, Majeed A, Fadahunsi KP, O’Donoghue J. Impact of mobile health applications on self-management in patients with type 2 diabetes mellitus: protocol of a systematic review. BMJ Open. 2019;9(6):e025714. DOI: 10.1136/bmjopen-2018-025714
  2. Li W, Jin L, Cui Y, Nie A, Xie N, Liang G. Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repression. J Endocrinol Invest. 2021;44(6):1193-207. DOI: 10.1007/s40618-020-01405-3
  3. Louie HH, Shome A, Kuo CY, Rupenthal ID, Green CR, Mugisho OO. Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy. Exp Eye Res. 2021;202:108384. DOI: 10.1016/j. exer.2020.108384
  4. Yu HS, Hong EH, Shin YU, Koh SH, Cho H. ATP-binding cassette subfamily A-1 (ABCA1) levels are increased in the aqueous humour of proliferative diabetic retinopathy patients. Acta Ophthalmol. 2021;99(3):e442-3. DOI: 10.1111/aos.14550
  5. Horakova D, Stepanek L, Nagelova R, Pastucha D, Azeem K, Kollarova H. Total and high-molecular-weight adiponectin levels and prediction of insulin resistance. Endokrynol Pol. 2018;69:375-80. DOI: 10.5603/EP.a2018.0035
  6. Juuti-Uusitalo K, Nieminen M, Treumer F, Ampuja M, Kallioniemi A, Klettner A, et al. Effects of Cytokine Activation and Oxidative Stress on the Function of the Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells. Invest Ophthalmol Vis Sci. 2015;56(11):6265-74. DOI: 10.1167/iovs.15-17333
  7. Maturi RK, Glassman AR, Josic K, Antoszyk AN, Blodi BA, Jampol LM, et al. Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial. JAMA Ophthalmol. 2021;139(7):701-12. DOI: 10.1001/jamaophthalmol.2021.0606
  8. Xu W, Geng H, Liu X, Wang X, Li R, Lv Q, et al. Wingless-type MMTV integration site family member 5a: a novel biomarker regulated in type 2 diabetes mellitus and diabetic kidney disease. J Diabetes Metab Disord. 2019;18(2):525-32. DOI: 10.1007/s40200-019-00461-8
  9. Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2012;12(4):346-54. DOI: 10.1007/s11892-012-0283-6
  10. Simó-Servat O, Hernández C, Simó R. Diabetic Retinopathy in the Context of Patients with Diabetes. Ophthalmic Res. 2019;62(4):211-7. DOI: 10.1159/000499541
  11. Saw M, Wong VW, Ho IV, Liew G. New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy. Eye (Lond). 2019;33(12):1842-51. DOI: 10.1038/s41433-019-0494-z
  12. Grzybowski A, Brona P, Lim G, Ruamviboonsuk P, Tan GSW, Abramoff M, et al. Artificial intelligence for diabetic retinopathy screening: a review. Eye. 2020;34:451-60. DOI: 10.1038/s41433-019-0566-0
  13. Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021;12(8):1322-5. DOI: 10.1111/jdi.13480
  14. Khan SZ, Ajmal N, Shaikh R. Diabetic Retinopathy and Vascular Endothelial Growth Factor Gene Insertion/Deletion Polymorphism. Can J Diabetes. 2020;44(3):287-91. DOI: 10.1016/j.jcjd.2019.08.005
  15. Frank RN. Anti-Vascular Endothelial Growth Factor Injections for Diabetic Retinopathy: Continued Progress, More Questions. Ophthalmology. 2019;126(5):721-2. DOI: 10.1016/j.ophtha.2018.11.011
  16. Kato K, Osawa H, Ochi M, Kusunoki Y, Ebisui O, Ohno K, et al. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy. Clin Endocrinol. 2008;68(3):442-9. DOI: 10.1111/j.1365-2265.2007.03063.x
  17. Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, et al. Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy. JAMA. 2023;329(5):376-85. DOI: 10.1001/jama.2022.25029
  18. Liu LB, Chen XD, Zhou XY, Zhu Q. The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation, and type 2 diabetes mellitus. Biosci Rep. 2018;38(4):BSR20180011. DOI: 10.1042/BSR20180011
  19. Zhu DD, Wang YZ, Zou C, She XP, Zheng Z. The role of uric acid in the pathogenesis of diabetic retinopathy based on Notch pathway. Biochem Biophys Res Commun. 2018;503(2):921-9. DOI: 10.1016/j.bbrc.2018.06.097
  20. Fan J, Shen W, Lee SR, Mathai AE, Zhang R, Xu G, et al. Targeting the Notch and TGF-β signaling pathways to prevent retinal fibrosis in vitro and in vivo. Theranostics. 2020;10(18):7956-73. DOI: 10.7150/thno.45192
DOI: https://doi.org/10.2478/rrlm-2023-0028 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 241 - 250
Submitted on: Mar 9, 2023
|
Accepted on: Sep 23, 2023
|
Published on: Oct 28, 2023
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Yanfang Fu, Shizhen Ye, Jianjun Peng, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.